Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Alzheimer's Disease

Free Subscription Articles published in Alzheimers Dement Retrieve available abstracts of 101 articles: HTML format Text format

Single Articles

May 2012
1. YAFFE K , Tocco M, Petersen RC, Sigler C, et al
   The epidemiology of Alzheimer's disease: Laying the foundation for drug design, conduct, and analysis of clinical trials.
   Alzheimers Dement. 2012;8:237-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. KHACHATURIAN ZS , Khachaturian AS, Thies W
   The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA).
   Alzheimers Dement. 2012;8:234-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. COTE S , Carmichael PH, Verreault R, Lindsay J, et al
   Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease.
   Alzheimers Dement. 2012;8:219-26.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RODRIGUEZ MJ , Potter E, Shen Q, Barker W, et al
   Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
   Alzheimers Dement. 2012;8:211-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SPARKS STEIN P , Steffen MJ, Smith C, Jicha G, et al
   Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease.
   Alzheimers Dement. 2012;8:196-203.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
6. BRAAK H , Del Tredici K
   Alzheimer's disease: Pathogenesis and prevention.
   Alzheimers Dement. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. BALSIS S , Unger AA, Benge JF, Geraci L, et al
   Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: A comparison of item response theory-based scores and total scores.
   Alzheimers Dement. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. BECKER RE , Greig NH
   Fire in the ashes: Can failed Alzheimer's disease drugs succeed with second chances?
   Alzheimers Dement. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LANE RM , He Y
   Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype.
   Alzheimers Dement. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. 
    2012 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2012;8:131-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MIELKE MM , Okonkwo OC, Oishi K, Mori S, et al
    Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.
    Alzheimers Dement. 2012;8:105-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
12. DRYE LT , Ismail Z, Porsteinsson AP, Rosenberg PB, et al
    Citalopram for agitation in Alzheimer's disease: Design and methods.
    Alzheimers Dement. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. MIELKE MM , Leoutsakos JM, Corcoran CD, Green RC, et al
    Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.
    Alzheimers Dement. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
14. RODGERS C
    WITHDRAWN: Are dental X-rays causing Alzheimer's? Ten reasons to take a closer look.
    Alzheimers Dement. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. LYKETSOS CG , Miller DS
    Addressing the Alzheimer's disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes.
    Alzheimers Dement. 2012;8:60-4.
    PubMed     Text format     Related articles   
    
    
    
    
16. FURIAK NM , Kahle-Wrobleski K, Callahan C, Klein TM, et al
    Screening and treatment for Alzheimer's disease: Predicting population-level outcomes.
    Alzheimers Dement. 2012;8:31-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HYMAN BT , Phelps CH, Beach TG, Bigio EH, et al
    National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
    Alzheimers Dement. 2012;8:1-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HOOLI B , Bertram L, Parrado A, Tanzi R, et al
    Retraction. Genome-wide assessment of copy number variations in early-onset Alzheimer's disease.
    Alzheimers Dement. 2012;8:86.
    PubMed     Text format     Related articles   
    
    
    
    December 2011
19. CHEN R
    Association of environmental tobacco smoke with dementia and Alzheimer's disease among never smokers.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. HENLEY DB , Sundell KL, Sethuraman G, Siemers ER, et al
    Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
21. GLASS DJ , Arnold SE
    Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. KOKJOHN TA , Maarouf CL, Roher AE
    Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ROSOW K , Holzapfel A, Karlawish JH, Baumgart M, et al
    Countrywide strategic plans on Alzheimer's disease: Developing the framework for the international battle against Alzheimer's disease.
    Alzheimers Dement. 2011;7:615-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. GILLETTE-GUYONNET S , Andrieu S, Nourhashemi F, Gardette V, et al
    Long-term progression of Alzheimer's disease in patients under antidementia drugs.
    Alzheimers Dement. 2011;7:579-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ANDREOLI V , Trecroci F, La Russa A, Cittadella R, et al
    Presenilin enhancer-2 gene: Identification of a novel promoter mutation in a patient with early-onset familial Alzheimer's disease.
    Alzheimers Dement. 2011;7:574-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KHACHATURIAN ZS
    Prospects for designating Alzheimer's disease research a national priority.
    Alzheimers Dement. 2011;7:557-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
27. WEINER MW , Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. VANDERSTICHELE H , Bibl M, Engelborghs S, Le Bastard N, et al
    Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. MUSIEK ES , Chen Y, Korczykowski M, Saboury B, et al
    Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
30. KULLER LH , Lopez OL
    Dementia and Alzheimer's disease: A new direction. The 2010 Jay L. Foster Memorial Lecture.
    Alzheimers Dement. 2011;7:540-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LYKETSOS CG , Carrillo MC, Ryan JM, Khachaturian AS, et al
    Neuropsychiatric symptoms in Alzheimer's disease.
    Alzheimers Dement. 2011;7:532-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
32. GOMENI R , Simeoni M, Zvartau-Hind M, Irizarry MC, et al
    Modeling Alzheimer's disease progression using the disease system analysis approach.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. COLEY N , Andrieu S, Jaros M, Weiner M, et al
    Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. TANG JX , Mardini F, Caltagarone BM, Garrity ST, et al
    Anesthesia in presymptomatic Alzheimer's disease: A study using the triple-transgenic mouse model.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. JACK CR JR , Barkhof F, Bernstein MA, Cantillon M, et al
    Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.
    Alzheimers Dement. 2011;7:474-485.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. GUSTAVSSON A , Cattelin F, Jonsson L
    Costs of care in a mild-to-moderate Alzheimer clinical trial sample: Key resources and their determinants.
    Alzheimers Dement. 2011;7:466-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. BREITNER JC , Baker LD, Montine TJ, Meinert CL, et al
    Extended results of the Alzheimer's disease anti-inflammatory prevention trial.
    Alzheimers Dement. 2011;7:402-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. CARLSON C , Estergard W, Oh J, Suhy J, et al
    Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab.
    Alzheimers Dement. 2011;7:396-401.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. MATTSSON N , Andreasson U, Persson S, Arai H, et al
    The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.
    Alzheimers Dement. 2011;7:386-395.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. SPERLING RA , Jack CR Jr, Black SE, Frosch MP, et al
    Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup.
    Alzheimers Dement. 2011;7:367-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ANTUNEZ C , Boada M, Lopez-Arrieta J, Moreno-Rey C, et al
    Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease.
    Alzheimers Dement. 2011;7:e124-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. VELLAS B , Pesce A, Robert PH, Aisen PS, et al
    AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials.
    Alzheimers Dement. 2011;7:e109-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SHEN Q , Loewenstein DA, Potter E, Zhao W, et al
    Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.
    Alzheimers Dement. 2011;7:e101-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. 
    Alzheimer's association update July 2011.
    Alzheimers Dement. 2011;7:490-491.
    PubMed     Text format     Related articles   
    
    
    
    
45. JOHNSON SC , La Rue A, Hermann BP, Xu G, et al
    The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3/epsilon3 genotype.
    Alzheimers Dement. 2011;7:456-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. 
    Abstracts of the Alzheimer's Imaging Consortium. July 16-21, 2011. Paris, France.
    Alzheimers Dement. 2011;7.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
47. CABRAL D , Beach TG, Vedders L, Sue LI, et al
    Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. LOGUE MW , Posner H, Green RC, Moline M, et al
    Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. SCHIPPER HM
    Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. WEINER MW , Sadowsky C, Saxton J, Hofbauer RK, et al
    Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
51. DODGE HH , Chang CC, Kamboh IM, Ganguli M, et al
    Risk of Alzheimer's disease incidence attributable to vascular disease in the population.
    Alzheimers Dement. 2011;7:356-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. HERRUP K
    Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.
    Alzheimers Dement. 2011;7:335-7.
    PubMed     Text format     Related articles   
    
    
    
    
53. KORCZYN AD
    Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.".
    Alzheimers Dement. 2011;7:333-4.
    PubMed     Text format     Related articles   
    
    
    
    
54. GAUTHIER S , Patterson C, Gordon M, Soucy JP, et al
    Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective.
    Alzheimers Dement. 2011;7:330-2.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. LYKETSOS CG
    Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." New criteria for a new era.
    Alzheimers Dement. 2011;7:328-9.
    PubMed     Text format     Related articles   
    
    
    
    
56. GUSTAVSSON A , Brinck P, Bergvall N, Kolasa K, et al
    Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients.
    Alzheimers Dement. 2011;7:318-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. MARSHALL GA , Rentz DM, Frey MT, Locascio JJ, et al
    Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease.
    Alzheimers Dement. 2011;7:300-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. KHACHATURIAN ZS
    Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.
    Alzheimers Dement. 2011;7:253-6.
    PubMed     Text format     Related articles   
    
    
    
    
59. AISEN PS
    Commentary on "Biomarkers in Alzheimer's disease drug development." Can't live without 'em.
    Alzheimers Dement. 2011;7:e48-50.
    PubMed     Text format     Related articles   
    
    
    
    
60. WEINER MW
    Commentary on "Biomarkers in Alzheimer's disease drug development." The view from Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2011;7:e45-7.
    PubMed     Text format     Related articles   
    
    
    
    
61. CUMMINGS JL
    Biomarkers in Alzheimer's disease drug development.
    Alzheimers Dement. 2011;7:e13-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. SEGAL-GIDAN F , Cherry D, Jones R, Williams B, et al
    Alzheimer's disease management guideline: update 2008.
    Alzheimers Dement. 2011;7:e51-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. MCKHANN GM , Knopman DS, Chertkow H, Hyman BT, et al
    The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Alzheimers Dement. 2011;7:263-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. ALBERT MS , DeKosky ST, Dickson D, Dubois B, et al
    The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Alzheimers Dement. 2011;7:270-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. SPERLING RA , Aisen PS, Beckett LA, Bennett DA, et al
    Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Alzheimers Dement. 2011;7:280-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. JACK CR JR , Albert MS, Knopman DS, McKhann GM, et al
    Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Alzheimers Dement. 2011;7:257-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. KADDURAH-DAOUK R , Rozen S, Matson W, Han X, et al
    Metabolomic changes in autopsy-confirmed Alzheimer's disease.
    Alzheimers Dement. 2011;7:309-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
68. GETSIOS D , Blume S, Ishak KJ, Maclaine G, et al
    An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. ROHER AE , Tyas SL, Maarouf CL, Daugs ID, et al
    Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. ROHER AE , Garami Z, Tyas SL, Maarouf CL, et al
    Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease.
    Alzheimers Dement. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. DONOHUE MC , Gamst AC, Aisen PS
    Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
    Alzheimers Dement. 2011;7:245-6.
    PubMed     Text format     Related articles   
    
    
    
    
72. THIES W , Bleiler L
    2011 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2011;7:208-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. DOODY RS , Cole PE, Miller DS, Siemers E, et al
    Global issues in drug development for Alzheimer's disease.
    Alzheimers Dement. 2011;7:197-207.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. THIES W
    Stopping a thief and killer: Alzheimer's disease crisis demands greater commitment to research.
    Alzheimers Dement. 2011;7:175-6.
    PubMed     Text format     Related articles   
    
    
    
    
75. FRISONI GB , Jack CR
    Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use.
    Alzheimers Dement. 2011;7:171-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. KHACHATURIAN ZS , Petersen RC, Snyder PJ, Khachaturian AS, et al
    Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.
    Alzheimers Dement. 2011;7:127-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. WEIGAND SD , Vemuri P, Wiste HJ, Senjem ML, et al
    Transforming cerebrospinal fluid Abeta42 measures into calculated Pittsburgh Compound B units of brain Abeta amyloid.
    Alzheimers Dement. 2011;7:133-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. KARLAWISH J , Barg FK, Augsburger D, Beaver J, et al
    What Latino Puerto Ricans and non-Latinos say when they talk about Alzheimer's disease.
    Alzheimers Dement. 2011;7:161-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. CHEN W , Song X, Beyea S, D'Arcy R, et al
    Advances in perfusion magnetic resonance imaging in Alzheimer's disease.
    Alzheimers Dement. 2011;7:185-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. SMALL G , Bullock R
    Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease.
    Alzheimers Dement. 2011;7:177-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. ITO K , Corrigan B, Zhao Q, French J, et al
    Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database.
    Alzheimers Dement. 2011;7:151-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
82. DEKOSKY ST , Carrillo MC, Phelps C, Knopman D, et al
    Revision of the criteria for Alzheimer's disease: A symposium.
    Alzheimers Dement. 2011;7:e1-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. EVANS DA , Grodstein F, Loewenstein D, Kaye J, et al
    Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2.
    Alzheimers Dement. 2011;7:110-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. WEIR DR , Wallace RB, Langa KM, Plassman BL, et al
    Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1.
    Alzheimers Dement. 2011;7:94-109.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. ROCCA WA , Petersen RC, Knopman DS, Hebert LE, et al
    Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States.
    Alzheimers Dement. 2011;7:80-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. WILSON RS , Weir DR, Leurgans SE, Evans DA, et al
    Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States.
    Alzheimers Dement. 2011;7:74-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. BROOKMEYER R , Evans DA, Hebert L, Langa KM, et al
    National estimates of the prevalence of Alzheimer's disease in the United States.
    Alzheimers Dement. 2011;7:61-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. KNOPMAN DS , Petersen RC, Rocca WA, Larson EB, et al
    Passive case-finding for Alzheimer's disease and dementia in two U.S. communities.
    Alzheimers Dement. 2011;7:53-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. SESHADRI S , Beiser A, Au R, Wolf PA, et al
    Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2.
    Alzheimers Dement. 2011;7:35-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. MAYEUX R , Reitz C, Brickman AM, Haan MN, et al
    Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.
    Alzheimers Dement. 2011;7:15-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
91. MCLAUGHLIN T , Feldman H, Fillit H, Sano M, et al
    Dependence as a unifying construct in defining Alzheimer's disease severity.
    Alzheimers Dement. 2010;6:482-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. GEBHARDT FM , Scott HA, Dodd PR
    Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue.
    Alzheimers Dement. 2010;6:465-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. LOPEZ OL , Schwam E, Cummings J, Gauthier S, et al
    Predicting cognitive decline in Alzheimer's disease: an integrated analysis.
    Alzheimers Dement. 2010;6:431-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
94. IQBAL K , Grundke-Iqbal I
    Alzheimer's disease, a multifactorial disorder seeking multitherapies.
    Alzheimers Dement. 2010;6:420-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. WHITEHAIR DC , Sherzai A, Emond J, Raman R, et al
    Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
    Alzheimers Dement. 2010;6:412-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. OKONKWO OC , Alosco ML, Jerskey BA, Sweet LH, et al
    Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
    Alzheimers Dement. 2010;6:404-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. MIELKE MM , Haughey NJ, Ratnam Bandaru VV, Schech S, et al
    Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss.
    Alzheimers Dement. 2010;6:378-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. SCHNEIDER LS , Kennedy RE, Cutter GR
    Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
    Alzheimers Dement. 2010;6:367-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. BENDLIN BB , Ries ML, Canu E, Sodhi A, et al
    White matter is altered with parental family history of Alzheimer's disease.
    Alzheimers Dement. 2010;6:394-403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. COLANTUONI E , Surplus G, Hackman A, Arrighi HM, et al
     Web-based application to project the burden of Alzheimer's disease.
     Alzheimers Dement. 2010;6:425-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. CALCIANO MA , Zhou W, Snyder PJ, Einstein R, et al
     Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.
     Alzheimers Dement. 2010;6:386-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: